Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Celgene raises $250.9 million

CELG raised $250.9 million through the sale of 2.48 million shares at $101 per share in its follow-on

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE